Clinical Trial Update: Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma [Phase 1, Phase 2]

View source ↗

Summary

An update on a National Cancer Institute–sponsored Phase 1/Phase 2 trial evaluating a therapy for Ewing sarcoma, rhabdomyosarcoma, and neuroblastoma; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Neuroblastoma
• Peripheral Primitive Neuroectodermal Tumor
• Rhabdomyosarcoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neuroblastoma, Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-09-20